Tilray Brands Inc (TLRY)
1.34
+0.03
(+2.29%)
USD |
NASDAQ |
Nov 22, 16:00
1.345
0.00 (0.00%)
After-Hours: 20:00
Tilray Brands Price: 1.34 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 1.30 | 1.36 | 1.28 | 1.31 | 30.13M |
| Nov 20, 2024 | 1.31 | 1.325 | 1.28 | 1.29 | 27.93M |
| Nov 19, 2024 | 1.30 | 1.33 | 1.28 | 1.31 | 23.35M |
| Nov 18, 2024 | 1.33 | 1.35 | 1.30 | 1.32 | 29.28M |
| Nov 15, 2024 | 1.38 | 1.39 | 1.33 | 1.35 | 25.23M |
| Nov 14, 2024 | 1.44 | 1.45 | 1.38 | 1.38 | 21.47M |
| Nov 13, 2024 | 1.48 | 1.48 | 1.40 | 1.44 | 28.60M |
| Nov 12, 2024 | 1.39 | 1.51 | 1.36 | 1.47 | 42.20M |
| Nov 11, 2024 | 1.49 | 1.50 | 1.40 | 1.40 | 40.66M |
| Nov 08, 2024 | 1.54 | 1.55 | 1.48 | 1.49 | 28.49M |
| Nov 07, 2024 | 1.55 | 1.57 | 1.51 | 1.55 | 29.60M |
| Nov 06, 2024 | 1.63 | 1.690 | 1.50 | 1.54 | 56.07M |
| Nov 05, 2024 | 1.74 | 1.78 | 1.71 | 1.77 | 27.79M |
| Nov 04, 2024 | 1.68 | 1.82 | 1.67 | 1.73 | 66.27M |
| Nov 01, 2024 | 1.66 | 1.69 | 1.63 | 1.64 | 16.24M |
| Oct 31, 2024 | 1.68 | 1.69 | 1.63 | 1.64 | 13.78M |
| Oct 30, 2024 | 1.71 | 1.72 | 1.67 | 1.69 | 15.78M |
| Oct 29, 2024 | 1.72 | 1.77 | 1.70 | 1.71 | 23.32M |
| Oct 28, 2024 | 1.710 | 1.76 | 1.69 | 1.73 | 26.02M |
| Oct 25, 2024 | 1.64 | 1.73 | 1.64 | 1.69 | 28.36M |
| Oct 24, 2024 | 1.69 | 1.72 | 1.63 | 1.64 | 18.81M |
| Oct 23, 2024 | 1.70 | 1.74 | 1.66 | 1.68 | 30.93M |
| Oct 22, 2024 | 1.58 | 1.73 | 1.574 | 1.71 | 51.65M |
| Oct 21, 2024 | 1.58 | 1.60 | 1.57 | 1.58 | 10.46M |
| Oct 18, 2024 | 1.57 | 1.60 | 1.57 | 1.59 | 9.902M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.29
Minimum
Nov 20 2024
63.91
Maximum
Feb 10 2021
7.077
Average
4.23
Median
Price Benchmarks
| Aurinia Pharmaceuticals Inc | 8.88 |
| Edesa Biotech Inc | 2.17 |
| Lexaria Bioscience Corp | 2.07 |
| Xenon Pharmaceuticals Inc | 41.20 |
| ESSA Pharma Inc | 1.835 |
Price Related Metrics
| PS Ratio | 1.302 |
| Price to Book Value | 0.3480 |
| Earnings Yield | -20.15% |
| Market Cap | 1.210B |